Pharmaceutical PV DIV - FSB
Ended Awarded Last action
- Contract number
- SPE2DU26FC048
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,281
Award facts
- Contract value 100% obligated
- $11,281.21 Current and potential, with all options
- Completion date
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp has been awarded a delivery order valued at $11,281.21 by the Defense Logistics Agency under a firm fixed-price contract structure. The award, issued on January 21, 2026, with an ultimate completion date of the same day, represents a competitively awarded non-set-aside transaction for pharmaceutical products and medical supplies. The work will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that serves as the comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., is a major pharmaceutical distributor specializing in supplying prescription medications, generic drugs, vaccines, medical devices, and specialized healthcare commodities to federal medical procurement systems. The DLA Troop Support Medical IDC encompasses a broad spectrum of pharmaceutical products across multiple therapeutic domains including specialty medications, diabetes treatments, neurological therapies, pain management pharmaceuticals, and critical care materials to support Defense Health Agency, U.S. Coast Guard, and other government healthcare systems globally. Cencora maintains a parallel IDC valued at $999,999,999.00 through December 2031, underscoring the company's significant role in federal pharmaceutical supply chain operations.
Quick answers
Who was awarded contract SPE2DU26FC048?
SPE2DU26FC048 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DU26FC048 worth?
The government has obligated $11,281 on SPE2DU26FC048.
Is contract SPE2DU26FC048 an order under another contract?
Yes. SPE2DU26FC048 is a delivery order under SPE2DU25D4211, an indefinite delivery contract.
Was contract SPE2DU26FC048 competed?
The extent of competition for SPE2DU26FC048 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award